← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 9, 2017Last known activity
Jun 28, 2024
Timeline
2010s
- Jun 1, 2012
Intensity Therapeutics— Founded
Drugs by trial phase (4 distinct, 3 trials)
Phase 3 (4 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT06263231Lead sponsorPhase 3Jun 28, 2024
- NCT04781725CollaboratorPhase 2Mar 25, 2021
- NCT03058289Study directorPhase 1/Phase 2Feb 9, 2017
- NCT03058289Lead sponsorPhase 1/Phase 2Feb 9, 2017
Details
- Founded
- Norwalk, CT, US Jun 1, 2012
- Last known activity
- Jun 28, 2024